22NW, LP - MERRIMACK PHARMACEUTICALS IN ownership

MERRIMACK PHARMACEUTICALS IN's ticker is MACK and the CUSIP is 590328209. A total of 52 filers reported holding MERRIMACK PHARMACEUTICALS IN in Q1 2023. The put-call ratio across all filers is 0.61 and the average weighting 0.5%.

Quarter-by-quarter ownership
22NW, LP ownership history of MERRIMACK PHARMACEUTICALS IN
ValueSharesWeighting
Q4 2022$11,632,450
+152.0%
1,015,048
-17.5%
6.28%
+140.6%
Q3 2022$4,616,000
-37.5%
1,231,014
-0.9%
2.61%
-33.4%
Q2 2022$7,389,000
-5.9%
1,241,8960.0%3.92%
+37.5%
Q1 2022$7,855,000
+61.8%
1,241,8960.0%2.85%
+89.9%
Q4 2021$4,856,000
-19.0%
1,241,8960.0%1.50%
-15.9%
Q3 2021$5,998,000
-24.4%
1,241,8960.0%1.79%
-16.2%
Q2 2021$7,936,000
+1.8%
1,241,8960.0%2.13%
-11.2%
Q1 2021$7,799,000
-8.9%
1,241,8960.0%2.40%
-21.6%
Q4 2020$8,557,000
+72.2%
1,241,8960.0%3.06%
+21.6%
Q3 2020$4,968,000
+20.1%
1,241,8960.0%2.52%
+12.3%
Q2 2020$4,136,000
+54.9%
1,241,8960.0%2.24%
+8.0%
Q1 2020$2,670,000
-31.7%
1,241,8960.0%2.08%
-53.3%
Q4 2019$3,912,000
-30.0%
1,241,8960.0%4.44%
-39.8%
Q3 2019$5,589,000
-25.6%
1,241,8960.0%7.37%
-9.4%
Q2 2019$7,513,000
-1.0%
1,241,896
+13.7%
8.14%
+54.0%
Q1 2019$7,591,000
+162.5%
1,092,263
+45.8%
5.28%
+193.1%
Q4 2018$2,892,000749,3021.80%
Other shareholders
MERRIMACK PHARMACEUTICALS IN shareholders Q1 2023
NameSharesValueWeighting ↓
Western Standard LLC 1,894,013$23,353,18021.09%
Newtyn Management, LLC 1,873,694$23,102,6475.70%
Sio Capital Management, LLC 288,466$3,556,7861.10%
Madison Avenue Partners, LP 553,085$6,819,5380.97%
WITTENBERG INVESTMENT MANAGEMENT, INC. 209,739$2,5860.95%
Indaba Capital Management, L.P. 136,802$1,686,7690.50%
Sepio Capital, LP 306,680$3,781,3640.33%
Yakira Capital Management, Inc. 54,118$667,2750.18%
Centiva Capital, LP 187,803$2,315,6110.05%
FIFTH LANE CAPITAL, LP 10,929$134,4270.05%
View complete list of MERRIMACK PHARMACEUTICALS IN shareholders